The present invention relates to indole oxime derivatives of formula (I) wherein: R1 is -OH, -OC1-C8 alkyl, or NH2; R2 and R3 are, independently, hydrogen, C1-C8 alkyl, -CH2-C3-C6 cycloalkyl, -CH2-pyridinyl, phenyl, or benzyl; R4 is hydrogen, C1-C8 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, phenyl, benzyl, heteroaryl, or -CH2-heteoraryl; X is: formula (II), (III), (IV) or (V).The other substituents are defined in claim 1. The present compounds are PAI-1 inhibitors for the treatment of e.g. impairment of the fibrinolytic system, thrombosis or cardiovascular diseases.
本发明涉及式(I)的
吲哚肟衍
生物,其中:R1为-OH,-OC1-C8烷基,或NH2;R2和R3分别为氢,C1-C8烷基,-
CH2-C3-C6环烷基,- -
吡啶基,苯基,或苄基;R4为氢,C1-C8烷基,C3-C6环烷基,- -C3-C6环烷基,苯基,苄基,杂环烷基,或- -杂环烷基;X为:式(II),(III),(IV)或(V)。其他取代基在权利要求书中定义。本化合物是PAI-1
抑制剂,用于治疗如纤溶系统障碍、血栓形成或心血管疾病。